- NEWS
Diabetes risk rises after COVID, massive study finds
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-022-00912-y
References
Xie, Y. & Al-Aly, Z. Lancet Diabetes Endocrinol. https://doi.org/10.1016/S2213-8587(22)00044-4 (2022).
Wander, P. L. et al. Diabetes Care 45, 782–788 (2022).
Bowe, B., Xie, Y., Xu, E. & Al-Aly, Z. J. Am. Soc. Nephrol. 32, 2851–2862 (2021).
Xie, Y., Xu, E., Bowe, B. & Al-Aly, Z. Nature Med. 28, 583–590 (2022).
McKeigue, P. M. et al. Preprint at medRxiv https://doi.org/10.1101/2022.02.11.22270785 (2022).
Messaaoui, A., Hajselova, L. & Tenoutasse, S. J. Pediatr. Endocrinol. Metab. 34, 1319–1322 (2021).
Salmi, H. et al. Arch. Dis. Child 107, 180–185 (2022).
van der Heide, V. et al. Cell Rep. 38, 110508 (2022).